NovoCure Ltd (NVCR)
11.83
-0.26
(-2.15%)
USD |
NASDAQ |
Apr 22, 16:00
11.71
-0.12
(-1.01%)
Pre-Market: 09:21
NovoCure Free Cash Flow: -100.43M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -100.43M |
| September 30, 2023 | -89.19M |
| June 30, 2023 | -45.90M |
| March 31, 2023 | -4.605M |
| December 31, 2022 | 9.43M |
| September 30, 2022 | 19.70M |
| June 30, 2022 | 24.08M |
| March 31, 2022 | 36.01M |
| December 31, 2021 | 58.59M |
| September 30, 2021 | 106.18M |
| June 30, 2021 | 113.26M |
| March 31, 2021 | 99.13M |
| December 31, 2020 | 84.18M |
| September 30, 2020 | 40.36M |
| June 30, 2020 | 24.38M |
| March 31, 2020 | 21.62M |
| December 31, 2019 | 16.14M |
| Date | Value |
|---|---|
| September 30, 2019 | 27.25M |
| June 30, 2019 | 19.34M |
| March 31, 2019 | 3.715M |
| December 31, 2018 | -8.576M |
| September 30, 2018 | -28.44M |
| June 30, 2018 | -31.93M |
| March 31, 2018 | -30.09M |
| December 31, 2017 | -40.50M |
| September 30, 2017 | -52.78M |
| June 30, 2017 | -91.90M |
| March 31, 2017 | -120.79M |
| December 31, 2016 | -125.26M |
| September 30, 2016 | -137.37M |
| June 30, 2016 | -123.71M |
| March 31, 2016 | -113.85M |
| December 31, 2015 | -110.16M |
Free Cash Flow Range, Past 5 Years
-100.43M
Minimum
Dec 2023
113.26M
Maximum
Jun 2021
24.18M
Average
24.08M
Median
Jun 2022
Free Cash Flow Benchmarks
| AtriCure Inc | -37.51M |
| NeuroMetrix Inc | -6.268M |
| Repligen Corp | 74.93M |
| Teleflex Inc | 419.20M |
| Perspective Therapeutics Inc | -37.98M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -14.56M |
| Cash from Investing (Quarterly) | 98.50M |
| Cash from Financing (Quarterly) | 1.91M |
| Free Cash Flow Per Share (Quarterly) | -0.20 |
| Free Cash Flow to Equity (Quarterly) | -22.22M |
| Free Cash Flow to Firm (Quarterly) | -21.38M |
| Free Cash Flow Yield | -7.98% |